Ocugen Inc (OCGN)

[BarrellofHay]

The key points to this investment is that you are now a shareholder of Ocugen and your shares will be worth 10% of whatever value the market will attribute to this company when the shares convert. Does not matter how shares are distributed or rearranged or who they are sold too. You will receive 10% of that market value. The big unknowns are:

1. How much cash does Ocugen have?
2. what kind of equity agreements are in place with other Pharma if any?
3. what is the market for their products?
4. How fast are they burning capital
5. who are the current investors and how many shares are they going to sell (how much are they going to raise)?
6. Timing of Phase 3 trials and ultimately to market

Lots of unknowns but as of now the company is valued at: 17 million x 10 = 170 million.
This is pretty low for a Phase III biotech with a compelling drug portfolio
Note: their phase III timeline is very short at 28 days, so data will be coming very soon. Does not take much time to discover if some of their products work unlike oncology.

I think it is worth between 400-800 million, which equals 2-4 times todays price. Only sell if you think its worth less than 200 million.

Also, they will absorb 15 million in cash and all HSGX assets

We will need to see the prospectus in order to get more information and many are waiting until it is out.